{
  "timestamp": "2026-01-05T07:06:24.200058",
  "agent_id": "medication_management",
  "phase": "complete",
  "input_data": null,
  "prompt": null,
  "llm_response": null,
  "output_data": {
    "clarification_needed": false,
    "clarification_question": "",
    "suggested_answer": "",
    "medications": [
      {
        "name": "Sertraline",
        "generic_name": "Sertraline",
        "brand_name": "Zoloft",
        "strength": "100mg",
        "form": "Tablet",
        "route": "Oral",
        "frequency": "Daily",
        "indication": "Recurrent Major Depressive Disorder",
        "response": "Inadequate response to 50mg dose after 4 weeks.",
        "adherence": "Excellent (Reported taking 50mg daily as prescribed)",
        "side_effects": []
      }
    ],
    "changes_made": [
      {
        "medication": "Sertraline",
        "change_type": "Increase Dose",
        "rationale": "Suboptimal therapeutic response (persistence of severe symptoms including anhedonia, early morning awakening, and passive death ideation) after 4-week trial at 50mg. Escalation to 100mg for increased efficacy.",
        "previous_dose": "50mg",
        "new_dose": "100mg"
      }
    ],
    "peer_review_status": {
      "diagnosis_mapping": "**F33.1** (Recurrent Major Depressive Disorder, Moderate)",
      "medication_class": "SSRI",
      "match_assessment": "MATCH",
      "flag": "No",
      "notes": "*Sertraline* is first-line pharmacological treatment for **Major Depressive Disorder** and aligns with the proposed diagnosis of **F33.1**."
    }
  },
  "duration_ms": 5323,
  "error": null
}